Tarvanib 150 mg (Tablet)
Unit Price: ৳ 750.00 (1 x 14: ৳ 10,500.00)
Strip Price: ৳ 10,500.00
Medicine Details
| Category | Details |
|---|---|
| Generic | Erlotinib |
| Company | Jenphar bangladesh ltd |
| Also available as |
Title
- Tarvanib 150mg Tablet
Categories
- Medicine
- Cancer Therapy
Description
- Tarvanib is a kinase inhibitor used in the treatment of metastatic Non-Small Cell Lung Cancer (NSCLC) and locally advanced or metastatic Pancreatic Cancer. It functions by inhibiting the kinase activity of Epidermal Growth Factor Receptor (EGFR).
DosageAndAdministration
- Recommended daily doses for NSCLC and Pancreatic Cancer
- Dosage adjustments for concurrent use of CYP3A4 inhibitors and inducers
- Dose increment for concurrent cigarette smoking
Interaction
- Effects of co-administration with anticoagulants, CYP3A4 inhibitors, CYP3A4 inducers, and drugs affecting gastric pH
SideEffects
- Common adverse reactions and serious adverse reactions such as ILD, Renal Failure, and Gastrointestinal Perforation
PregnancyAndLactation
- Pregnancy category D
- Potential presence in human milk
PrecautionsAndWarnings
- Precautions for ILD, Renal Failure, Hepatotoxicity, Gastrointestinal Perforations, and Bullous skin disorders
UseInSpecialPopulations
- Lack of established safety and effectiveness in pediatric patients
- No significant differences in safety or efficacy in subjects 65 years and older
OverdoseEffects
- Tolerated single oral doses in healthy subjects and cancer patients
- Symptomatic treatment for suspected overdose
TherapeuticClass
- Targeted Cancer Therapy
StorageConditions
- Temperature and storage instructions